WO2015084923A1 - Urinary catheter protective tips having a fluid reservoir - Google Patents

Urinary catheter protective tips having a fluid reservoir Download PDF

Info

Publication number
WO2015084923A1
WO2015084923A1 PCT/US2014/068299 US2014068299W WO2015084923A1 WO 2015084923 A1 WO2015084923 A1 WO 2015084923A1 US 2014068299 W US2014068299 W US 2014068299W WO 2015084923 A1 WO2015084923 A1 WO 2015084923A1
Authority
WO
WIPO (PCT)
Prior art keywords
protective tip
catheter
sleeve
fluid
seal
Prior art date
Application number
PCT/US2014/068299
Other languages
French (fr)
Inventor
Padraig M. O'FLYNN
Seamus Fitzpatrick
Shamsedin Rostami
Original Assignee
Hollister Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52134428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2015084923(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hollister Incorporated filed Critical Hollister Incorporated
Priority to CA2923674A priority Critical patent/CA2923674C/en
Priority to LTEP14816051.8T priority patent/LT3077031T/en
Priority to DK14816051.8T priority patent/DK3077031T3/en
Priority to US14/914,822 priority patent/US10946172B2/en
Priority to AU2014360561A priority patent/AU2014360561B2/en
Priority to EP14816051.8A priority patent/EP3077031B1/en
Priority to ES14816051T priority patent/ES2841177T3/en
Publication of WO2015084923A1 publication Critical patent/WO2015084923A1/en
Priority to US17/153,184 priority patent/US11813412B2/en
Priority to US18/484,006 priority patent/US20240033478A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/008Strength or flexibility characteristics of the catheter tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0111Aseptic insertion devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0017Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/002Packages specially adapted therefor ; catheter kit packages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/20Closure caps or plugs for connectors or open ends of tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0062Catheters; Hollow probes characterised by structural features having features to improve the sliding of one part within another by using lubricants or surfaces with low friction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/008Strength or flexibility characteristics of the catheter tip
    • A61M2025/0081Soft tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains

Definitions

  • the present disclosure generally relates to urinary catheters. More particularly, the present disclosure relates to urinary catheters provided with a protective tip having a fluid reservoir.
  • Intermittent catheterization is a good option for many users who suffer from various abnormalities and pathologies of the urinary system and its nerve supply.
  • catheters are typically provided as single use, individually packaged items and may include a gel-lubricant or hydrophilic coating as a lubricant for reducing friction during insertion into the urethra.
  • a user applies a gel-lubricant, such as a water-based gel-lubricant, to the surface of the catheter, which reduces friction for ease of insertion into the urethra.
  • a gel-lubricant such as a water-based gel-lubricant
  • the gel-lubricant is supplied with the packaged catheter, in which case the gel-lubricant may be applied to the catheter surface just before or during the packaging operation or as the catheter is being inserted by the user.
  • hydrophilic material When a hydrophilic material is used as a lubricant, a thin coating of hydrophilic material is applied to the outer surface of the catheter, and may subsequently be radiation- or heat-cured. When this coating is activated by swelling in contact with a hydrating liquid or wetting agent such as water, it provides a hydrated surface having an extremely low coefficient of friction.
  • a hydrating liquid or wetting agent such as water
  • This product provides a sterile, individually packaged, single-use catheter in a dry state or condition. The user opens the package, pours water into the package, waits 30 seconds, and then removes the catheter from the package, which is now ready for insertion.
  • Other embodiments provide the amount of wetting agent necessary for immersion of the catheter in a separate compartment of the package.
  • the user must open the separate compartment of the package to allow the wetting agent to enter the catheter- containing chamber for direct contact with the hydrophilic coated surface.
  • the catheter is then removed from the package and inserted into the urethra.
  • the ready-to-use catheter is provided in a package that already contains enough loose wetting agent to cause it to be immersed. In such an embodiment, the user simply opens the package and removes the catheter therefrom, and then inserts the catheter into the urethra, without the need to add the wetting agent.
  • a disadvantage of the hydrophilic coated catheters described above is that the immersion liquid has a tendency to spill from the package as the user handles the catheter and tries to remove it for subsequent insertion.
  • a catheter assembly in one aspect, includes a sleeve, with a catheter at least partially positioned within the sleeve.
  • the catheter has a coating on at least a part of its length, which produces a low-friction surface on the catheter when treated with an activating substance.
  • a protective tip is connected to the sleeve and has proximal and distal internal seals, with the proximal seal positioned at the proximal end of the protective tip or between proximal and distal ends of the protective tip.
  • a cap has a projection removably received within the protective tip for sealing engagement with the proximal and distal seals to define a fluid reservoir within the protective tip.
  • An activating fluid is contained within the fluid reservoir.
  • a catheter assembly in another aspect, includes a sleeve, with a catheter at least partially positioned within the sleeve.
  • the catheter has a coating on at least a part of its length, which produces a low-friction surface on the catheter when treated with an activating substance.
  • a protective tip is connected to the sleeve and defines a fluid reservoir, with an activating fluid contained therein.
  • a cap has a projection removably received within the protective tip.
  • the catheter assembly also includes at least one fluid-tight film seal, with the film seal being positioned outside of the protective tip and extending between an outer surface of the protective tip and an outer surface of the cap or projection, within the fluid reservoir and extending between an internal surface of the protective tip and an outer surface of the projection, or within the sleeve and connected to a distal end of the protective tip.
  • Fig. 1 is a cross-sectional view of a proximal portion of an embodiment of a catheter assembly according to an aspect of the present disclosure
  • Fig. 2 is a side elevational view of the proximal portion of the catheter assembly of Fig. 1 ;
  • Fig. 3 is a side elevational view of the proximal portion of the catheter assembly of Fig. 1 , with a cap of the catheter assembly partially removed from a protective tip of the catheter assembly;
  • Fig. 4 is a side elevational view of the proximal portion of the catheter assembly of Fig. 1 , with a cap of the catheter assembly fully removed from a protective tip of the catheter assembly;
  • Fig. 5 is a side elevational view of the catheter assembly of Fig. 1 ;
  • Fig. 6 is a cross-sectional view of a proximal portion of another
  • Fig. 7 is a cross-sectional view of a proximal portion of yet another embodiment of a catheter assembly according to an aspect of the present disclosure
  • Fig. 8 is a cross-sectional view of a proximal portion of another embodiment of a catheter assembly according to an aspect of the present disclosure
  • Fig. 9 is a cross-sectional view of a proximal portion of yet another embodiment of a catheter assembly according to an aspect of the present disclosure.
  • Fig. 10 is a side elevational view of a catheter assembly incorporating an alternative sleeve according to an aspect of the present disclosure.
  • Fig. 1 1 is a side elevational view of a catheter assembly incorporating another alternative sleeve according to an aspect of the present disclosure.
  • Figs. 1 and 2 illustrate an embodiment of a catheter assembly 1 0, such as a urinary catheter assembly.
  • the catheter assembly 10 may be variously configured without departing from the scope of the present disclosure, but in one embodiment, the catheter assembly 10 includes a catheter 12 (such as a urinary catheter) at least partially positioned within a sleeve 14, which may be defined by a flexible polymeric material (such as, but not limited to, polyurethane) wrapped about the catheter 12.
  • a protective tip 16 is secured or connected to a proximal end 18 of the sleeve 14, with an opposite or distal end 20 of the sleeve 14 (Fig. 5) being sealed or otherwise closed to define a sealed container for the catheter 16.
  • the protective tip 16 extends between a distal end 22 and a proximal end 24.
  • the protective tip 16 is sealingly connected or secured to the sleeve 14 at or adjacent to the distal end 22 of the protective tip 1 6.
  • the proximal end 24 of the protective tip 1 6 may include an aperture or opening 26 that may be moved between a closed configuration (in which the catheter 12 is fully positioned within the sleeve 14 and protective tip 1 6 and there is no other object positioned within the opening 26) and an open configuration (in which the catheter 12 or any other object is partially positioned within or extending through the opening 26, with a portion of the object positioned within the protective tip 16 and another portion positioned outside of the protective tip 16).
  • the opening 26 is provided as a slit opening with one or more slits or cuts defining a plurality of deformable petals that may be moved to define the aforementioned open and closed configurations.
  • the opening may be differently configured, provided that it is configured to allow passage of the catheter therethrough.
  • the protective tip 16 may include an internal proximal seal or sealing surface or sealing member 28 and an internal distal seal or sealing surface or sealing member 30 (Fig. 1 ), with the seals 28 and 30 being spaced from each other and at least the proximal seal 28 positioned between the proximal and distal ends 24 and 22 of the protective tip 16.
  • the catheter assembly 10 may further include a cap 32 configured to be removably connected to the protective tip 16.
  • the cap 32 may be connected to a proximal portion of the protective tip 16 so as to form a substantially fluid- or water-tight seal, which encloses the opening 26 at the proximal end 24 of the protective tip 16.
  • the cap 32 includes a projection or extension or plug 34, which is shown as being elongated along a central axis of the cap 32. While the projection 34 is illustrated as having a solid, substantially cylindrical configuration with a substantially uniform outer diameter, it is also within the scope of the present disclosure for the projection 34 to be differently configured (e.g., non-cylindrical).
  • the projection 34 When the cap 32 has been mounted onto the protective tip 16, the projection 34 is at least partially positioned within the protective tip 16, as shown in Fig. 1 .
  • the projection 34 extends through the proximal opening 26 of the protective tip 1 6 (with the projection 34 holding the opening 26 in an at least partially open configuration) to sealingly cooperate with the protective tip 16 (or a component thereof) to provide the proximal and distal seals 28 and 30.
  • the projection 34 engages the protective tip 16 (or a component thereof) in at least three locations: at the proximal opening 26, at the proximal seal 28, and at the distal seal 30.
  • each seal 28, 30 may be configured to define an opening or aperture with a cross-sectional shape that is comparable to the cross-sectional shape of the projection 34.
  • the projection 34 is substantially cylindrical (as in the illustrated embodiment), with a substantially circular cross- sectional shape, each of the internal seals 28, 30 may substantially annular to define a central circular opening or aperture.
  • one or both of the internal seals 28 and 30 may be configured to define openings or apertures which are similarly non-circularly configured to match the cross-sectional shape of the projection 34.
  • the openings or apertures defined by the internal seals 28 and 30 may be slightly smaller than the portion of the projection 34 which is positioned within the opening or aperture when the cap 32 has been mounted onto the protective tip 16. Such a configuration may be preferred in order to promote a fluid- or water-tight seal at each internal seal 28, 30, but it is also within the scope of the present disclosure for the openings or apertures defined by the internal seals 28 and 30 to have a size and shape substantially identical to that of the corresponding portion of the projection 34.
  • the internal seals 28 and 30 may be formed of a deformable material to allow the seal to deform outwardly to accommodate the larger cross-section of the projection 34.
  • the internal seals 28 and 30 of the protective tip 1 6 may be formed of an elastomeric material (e.g., an O-ring), which provides a fluid- or water-tight seal while being deformable.
  • elastomeric material e.g., an O-ring
  • different materials such as silicone; the polyether block amide material marketed as PEBAX® by Arkema S.A.
  • proximal seal 28 may be formed of a different material than the distal seal 30.
  • the proximal and distal internal seals 28 and 30 may be inner surfaces of the protective tip 16 or may be directly connected to the inner surface of the protective tip 1 6 or may be connected to the inner surface of the protective tip 16 via an intermediate member.
  • the inner surface of the protective tip 1 6 has a greater diameter at its distal end 22 than at its proximal end 24.
  • a grommet or spacer or intermediate member 36 it may be advantageous for a grommet or spacer or intermediate member 36 to be connected to the inner surface of the protective tip 16 (Fig. 1 ), with the grommet 36 defining an opening or aperture in which the distal seal 30 may be formed.
  • the distal seal 30 may be positioned closer to the central axis of the protective tip 1 6 without increasing the size of the distal seal 30.
  • the grommet 36 itself (as a component of the protective tip 16) may provide an internal seal or sealing surface which sealingly engages the projection 34.
  • the material composition of the grommet 36 may vary without departing from the scope of the present disclosure, but in one embodiment, the grommet 36 is a generally annular member comprised of a generally rigid or semi-rigid material having a relatively low water permeability.
  • the grommet 36 may be made from a thermoplastic elastomer, such as a non-swellable polyolefin material or PEBAX® or the like.
  • a fluid reservoir or compartment 38 is defined between the internal seals 28 and 30 of the protective tip 16 (Fig. 1 ).
  • An activating or hydrating fluid may be contained within the fluid reservoir 38, which fluid is configured to interact with a coating (such as, but not limited to, a hydrophilic coating) on the catheter 12 to provide a lubricious surface to the catheter 12.
  • a coating such as, but not limited to, a hydrophilic coating
  • the nature of the activating fluid may vary depending on the nature of the coating on the catheter 12 but, in one
  • the activating fluid is water.
  • the fluid reservoir 38 is at least partially filled with the activating fluid during manufacture (e.g., between 2 and 5 ml of activating fluid) and remains within the fluid reservoir 38 during storage and until the catheter assembly 10 is used, as described below.
  • the fluid reservoir 38 may be filled with the activating fluid by any suitable method, but in one embodiment, the activating fluid may be dispensed into the fluid reservoir 38 while only one of the seals 28 and 30 is in place.
  • activating fluid in a container may be inserted into the fluid reservoir 38, with the container being dissolved (in the case of a water- soluble container) or otherwise manipulated or processed to release the activating fluid into the fluid reservoir 38 after the fluid reservoir 38 has been sealed.
  • a container e.g., a water-soluble polymer pouch or container
  • Other methods of dispensing activating fluid into the fluid reservoir 38 may be employed without departing from the scope of the present disclosure.
  • the fluid reservoir 38 is intended to house the activating fluid during storage of the catheter assembly 10, it may be preferred for the protective tip 1 6 (or at least the portion defining the fluid reservoir 38) to be formed of a rigid or semi-rigid material having a relatively low water permeability (e.g., polyethylene).
  • the projection 34 of the cap 32 is intended to be at least partially positioned within the fluid reservoir 38 during storage of the catheter assembly 10, so it may be advantageous for the cap 32 (or at least the projection 34) to be formed of a rigid or semi-rigid material having a relatively low water permeability.
  • the fluid reservoir 38 and the projection 34 are formed of the same material, which may also be the same material as is used to form the grommet 36, but in other embodiments, the fluid reservoir 38, the projection 34, and the grommet 36 may be formed of different materials.
  • the catheter assembly 10 is provided to a user in the configuration shown in Figs. 1 and 2.
  • the catheter assembly 10 may be enclosed within a sealed package or container (not illustrated) that must be opened by the user prior to use of the catheter assembly 1 0.
  • a sealed package or container not illustrated
  • the cap 32 and sleeve 14 serve as a sealed package for the catheter 12.
  • the user partially withdraws the cap 32 from the protective tip 1 6 (Fig. 3) so as to disengage the projection 34 from the distal internal seal 30.
  • the activating fluid is allowed to flow out of the fluid reservoir 38 and into the sleeve 14 via the opening or aperture defined by the distal seal 30.
  • the catheter assembly 10 may be held vertically by the user, with the cap 32 and protective tip 1 6 pointing upwardly, to promote flow of the activating fluid out of the fluid reservoir 38 and into the sleeve 14.
  • the projection 34 maintains the proximal internal seal 28, thereby preventing the activating fluid from flowing out of the proximal opening 26 of the protective tip 16.
  • the user may completely remove the cap 32 from the protective tip 1 6 to allow the activating fluid to flow from the fluid reservoir 38 into the sleeve 14.
  • the proximal opening 26 of the protective tip 16 in a closed configuration may provide a fluid- or water-tight seal to prevent the activating fluid from flowing out of the catheter assembly 10.
  • the activating fluid contacts the hydrophilic coating of the catheter 1 2 and interacts therewith to form a lubricious coating on the catheter 12.
  • the sleeve 14 is preferably formed of a substantially transparent or translucent material to allow the user to visually confirm that the activating fluid has covered the catheter 12 along the length of the coating. It may also be advantageous for the sleeve 14 to be formed of a flexible material to allow the user to manipulate the catheter 12 through the sleeve 14 to better apply the activating fluid to the coating of the catheter 12.
  • the sleeve 14 is formed of a soft, hydrophilic material, such as a polyurethane film, although other thin, soft film materials (either vapor permeable or impermeable) may also be used without departing from the scope of the present disclosure.
  • the cap 32 may be fully removed from the protective tip 16 (if it has only been partially withdrawn from the protective tip 16), as in Fig. 4, which moves the proximal opening 26 to its closed configuration. Thereafter, the lubricated catheter 1 2 may be advanced proximally into and through the protective tip 16 to exit the protective tip 1 6 via the proximal opening 26. If the catheter assembly 1 0 is provided as a urinary catheter assembly, the proximal end 24 (including the proximal opening 26) of the protective tip 16 may be positioned within the urethra prior to advancing the catheter 12 out of the proximal opening 26 of the protective tip 1 6.
  • the proximal end of the catheter 12 may be advanced out of the proximal opening 26 of the protective tip 16 and through the urethra until the proximal end of the catheter 12 reaches the bladder.
  • Urine within the bladder flows into the open interior of the catheter 12 via one or more eyes or openings 40 of the catheter 12 (Fig. 1 ), where it then flows through the catheter 12 and into the sleeve 14.
  • the distal end of the catheter 12 may include a funnel or drainage device 42 (Fig. 5) that allows urine to drain out of the catheter 12 and into a toilet or other waste receptacle. Thereafter, the catheter 12 may be removed from the urethra, with the catheter assembly 1 0 and urine being discarded after use.
  • Fig. 6 illustrates an alternative embodiment of a catheter assembly 10a according to the present disclosure.
  • the embodiment of Fig. 6 is similar to the catheter assembly 10 of Figs. 1 -5, with some differences in the configurations of the protective tip 16a and the cap 32a.
  • the protective tip 1 6a has a generally slimmer configuration than the protective tip 16 of Figs. 1 - 5, with the distal end 22a of the protective tip 16a having a diameter that is larger than that of the proximal end 24a, but with the diameters being more similarly sized than in the embodiment of Figs. 1 -5.
  • the embodiment of Figs. 1 illustrates an alternative embodiment of a catheter assembly 10a according to the present disclosure.
  • the embodiment of Fig. 6 is similar to the catheter assembly 10 of Figs. 1 -5, with some differences in the configurations of the protective tip 16a and the cap 32a.
  • the protective tip 1 6a has a generally slimmer configuration than the protective tip 16 of Figs. 1 - 5, with the dis
  • the distal seal 30 is provided at a grommet or spacer 36a, with the proximal seal 28 being provided at an inner surface of the protective tip 1 6a.
  • the configurations of the internal seals 28 and 30 may vary, as described above with regard to the embodiment of Figs. 1 -5.
  • the cap 32a As for the cap 32a, it varies from the cap 32 of Figs. 1 -5 in that its projection 34a defines a hollow portion or cavity 44 at a distal portion of the projection 34a.
  • a proximal end or portion of the catheter 12 may be positioned within the hollow portion 44 of the projection 34a during storage of the catheter assembly 10a, prior to use.
  • Such a configuration may be advantageous in that a shorter sleeve 14a may be employed, thereby decreasing the material cost of the catheter assembly 10a and the storage space required.
  • the catheter 12 has a smaller diameter than the distal seal 30 in the embodiment of Fig. 6, such that removing the cap 32a results in a gap or separation between the catheter 1 2 and the distal seal 30.
  • This separation between the catheter 12 and the distal seal 30 allows activating fluid to flow out of the protective tip 16a and into the sleeve 14a when the cap 32a (and, hence, the projection 34a) has been removed, thereby hydrating the portion of the catheter 12 positioned within the sleeve 14a.
  • Fig. 7 illustrates a variation of the embodiment of Fig. 6.
  • the catheter assembly 10b of Fig. 7 is substantially identical to the embodiment of Fig. 6, except that it is provided with an additional or third or auxiliary seal or flow-limiting feature 46.
  • the third seal 46 is positioned distally of the distal seal 30, at or adjacent to the distal end 22a of the protective tip 16a (i.e., outside and distally of the fluid reservoir 38).
  • the third seal 46 is configured to bear against the catheter 12, thereby forming either a fluid- or water-tight seal therewith or providing a flow-limiting feature.
  • the third seal 46 when providing a fluid- or water-tight seal, helps to maintain the activating fluid within the fluid reservoir 38 after the cap 32a is removed from the protective tip 16a by preventing the activating fluid from flowing into the sleeve 14a.
  • the activating fluid remains within the fluid reservoir 38, such that the catheter 1 2 (and the coating thereof) comes into contact with the activating fluid as the catheter 12 is advanced proximally through and out of the protective tip 16a, rather than the activating fluid contacting the coating within the sleeve 14a.
  • the third seal 46 is configured to provide a flow-limiting feature, at least a portion of the third seal 46 may be spaced away or separated from the outer surface of the catheter 12 to allow a regulated or limited flow of activating fluid into the sleeve 14a when the cap 32a is removed (as in the embodiment of Fig. 6).
  • the material composition of the third seal 46 may vary without departing from the scope of the present disclosure, but in one embodiment, the third seal 46 is formed of the same material as one or both of the other seals 28 and 30. In other embodiments, the third seal 46 may be formed of a different material than the other seals 28 and 30. Suitable materials for the third seal 46 include, but are not limited to, elastomeric materials, silicone, PEBAX®, thermoplastic
  • thermoplastic elastomers thermoplastic polyolefins, and other non-woven fabric materials.
  • Fig. 8 illustrates yet another embodiment of a catheter assembly 10c according to the present disclosure.
  • the catheter assembly 10c of Fig. 8 is comparable to the embodiment of Figs. 1 -5, except that it further includes a sponge or absorbent member 48 associated with the protective tip 16 to bear against the catheter 12.
  • the absorbent member 48 has a generally annular configuration and is associated with the grommet 36, seated within a counterbore or pocket or cavity 50 at a distal side or end of the grommet 36 (i.e., outside and distally of the fluid reservoir 38). By such a configuration, the absorbent member 48 absorbs and retains a portion of the activating fluid as it flows out of the fluid reservoir 38 and into the sleeve 14.
  • the absorbent member 48 As the catheter 12 is advanced proximally through the protective tip 16, it presses against the absorbent member 48, with the absorbent member 48 applying some of the retained activating fluid to the surface (and, hence, the hydrophilic coating) of the catheter 12. This helps to ensure that activated fluid is applied to the entirety of the coated portion of the catheter 1 2 as the catheter 1 2 is advanced out of the protective tip 16.
  • the material composition of the absorbent member 48 may vary without departing from the scope of the present disclosure but, in one embodiment, the absorbent member 48 is formed of a sponge- or foam-like material, such as an open-cell sponge or foam material from foamed polymers (e.g., polyethylene or polyurethane or polyvinyl chloride) or the like.
  • Fig. 9 illustrates an alternative seal configuration.
  • the projection 34d of the cap 32d is spaced away from the protective tip 1 6d at the proximal end 24d of the protective tip 16d.
  • a proximal fluid-tight seal is provided between the protective tip 16d and the cap 32d by a fluid-tight film that is sealed to the two components, such as by heat seals.
  • one or both of the heat seals may be a peelable or breakable, as will be described in greater detail.
  • three fluid-tight films 52a, 52b, and 52c are provided, with a distal film 52c providing a distal seal, but it is within the scope of the present disclosure for the catheter assembly 10d to include only one or two such films.
  • the fluid-tight film seal or seals may be configured to provide only a proximal seal, only a distal seal, or both a proximal seal and a distal seal for the fluid reservoir 38.
  • One of the illustrated films 52a is provided within the protective tip 1 6d, at or adjacent to the proximal end 24d of the protective tip 16d.
  • the film 52a extends from the inner surface of the protective tip 1 6d to the outer surface of the cap projection 34d, being connected (e.g., by heat seals) to each component.
  • Another illustrated film 52b is positioned outside of the protective tip 16d, at or adjacent to the proximal end 24d of the protective tip 1 6d.
  • the second film 52b extends from the outer surface of the protective tip 16d to the outer surface of the cap 32d (or a portion of the projection 34d positioned outside of the protective tip 16d) and is connected (e.g., by heat seals) to each component.
  • the third illustrated film 52c is positioned within the sleeve 14 and is connected (e.g., by a heat seal) to the distal end 22d of the protective tip 16d and/or the grommet 36a of the protective tip 16d, overlaying the opening through which the catheter 12 may be advanced into the fluid reservoir 38.
  • the third film 52c may also be connected (e.g., by a heat seal) to the distal end of the cap projection 34d.
  • the cap 32d is moved proximally with respect to the protective tip 16d, thereby removing any slack in the films 52a, 52b, and 52c.
  • the slack in the proximal films 52a and 52b allows the projection 34d to separate from the distal seal 30 while the proximal seals provided by the films 52a and 52b remain intact.
  • the distal seal provided by the film 52c is broken before the proximal seals are broken, such that the activating fluid flows out of the fluid reservoir 38 (though the opening formerly sealed by the distal film 52c) and into the sleeve 14 to interact with the coating on the catheter 12.
  • the distal film 52c is connected to the distal end of the cap projection 34d and configured to break or detach from the protective tip 16d or grommet 36a upon sufficient proximal movement of the cap 32d.
  • the distal film 52c may be configured to be broken by proximal movement of the catheter 12 into contact with the film 52c.
  • the distal film 52c may be configured to dissolve over time (e.g., if the film 52c is formed of a water-soluble material), which allows the activating fluid to be released into the sleeve 14 during storage of the catheter assembly 10d for hydration of the catheter 1 2 over an extended period of time.
  • the distal film 52c may be configured to only weaken over time, without dissolving, thereby preventing activating fluid from entering the sleeve 14, while also making it easier for a user to break the distal seal.
  • proximal films 52a and 52b may either break upon application of sufficient force or may be peeled off to separate them from one or both of the associated components of the catheter assembly 10d. Breaking/peeling the heat seals of the films 52a and 52b allows for the cap 32d to be fully removed and separated from the protective tip 16d.
  • the film 52a positioned within the protective tip 16d may be configured to dissolve or weaken over time (e.g., if the film 52a is formed of a water-soluble material), which makes it easier for a user to break the seal and remove the cap 32d immediately prior to use.
  • Figs. 10 and 1 1 illustrate catheter assemblies 10e and 10f having alternatively configured sleeves 14e and 14f.
  • the illustrated sleeves 14e and 14f are configured to slow the rate at which activating fluid flows through the sleeve and to extend the time that the activating fluid is in contact with all coated areas of the catheter 12.
  • Either of the sleeves 14e and 14f may be used in combination with any of the catheter assemblies described herein or with other catheter assemblies in which an activating fluid flows through a catheter-containing sleeve.
  • the sleeve 14e is provided with a plurality of constrictions 54, but may have as few as one constriction 54.
  • the constrictions 54 effectively decrease the size of the gap between the sleeve 14e and the catheter 12, thereby preventing the activating fluid from quickly flowing through the sleeve 14e.
  • the exact flow rate of the activating fluid through the sleeve 14e and through the opening defined by each constriction 54 may be varied by adjusting the configuration of each constriction 54 (e.g., by increasing or decreasing the size of the opening defined by a constriction 54).
  • the constrictions 54 may be formed by any suitable method, but in one embodiment are formed by a heat sealing procedure that seals together opposing faces of the sleeve 14e.
  • the sleeve 14f is provided with a plurality of absorbent inserts 56, but may have as few as one absorbent insert 56.
  • the absorbent inserts 54 absorb a portion of the activating fluid as it flows through the sleeve 14f.
  • the sleeve 14f may be squeezed at the absorbent inserts 56 to transfer additional amounts of activating fluid from the absorbent inserts 56 to the catheter 12.
  • the configuration of the absorbent inserts 56 may vary, but it may be advantageous for them to be substantially annular and formed from a sponge- or foam-like non-woven fabric material, such as an open-cell sponge or foam material from foamed polymers (e.g., polyethylene or polyurethane or polyvinyl chloride) or the like.
  • the absorbent inserts 56 may be sealed or secured to the sleeve 14f by any suitable means, which may vary according to the material composition of the absorbent inserts 56 and the sleeve 14f.
  • a catheter assembly which includes a sleeve with a catheter at least partially positioned therein. There is a coating on at least a part of the catheter which produces a low-friction surface on the catheter when treated with an activating fluid.
  • a protective tip is connected to the sleeve and has proximal and distal internal seals, with the proximal seal being positioned at a proximal end of the protective tip or between proximal and distal ends of the protective tip.
  • a cap includes a projection removably received within the protective tip for sealing engagement with the proximal and distal seals to define a fluid reservoir within the protective tip, with an activating fluid contained within the fluid reservoir.
  • the projection has a substantially uniform outer diameter.
  • At least one of the internal seals is formed of a deformable material.
  • a grommet is secured to an inner surface of the protective tip, with the grommet defining an opening in which the distal internal seal is positioned.
  • a distal side of the grommet defines a pocket, with a generally annular absorbent member at least partially positioned within the pocket.
  • a distal portion of the projection defines a cavity in which a proximal end of the catheter is positionable.
  • a third internal seal is positioned distally of the distal internal seal, with the third internal seal being configured to bear against the catheter.
  • a third internal seal is positioned distally of the distal internal seal, with at least a portion of the third internal seal being separated from the catheter to provide a flow-limiting arrangement.
  • a catheter assembly which includes a sleeve with a catheter at least partially positioned therein. There is a coating on at least a part of the catheter which produces a low-friction surface on the catheter when treated with an activating fluid.
  • a protective tip is connected to the sleeve and defines a fluid reservoir, which contains an activating fluid.
  • a cap includes a projection removably received within the protective tip.
  • At least one fluid-tight film seal is positioned outside of the protective tip and extends between an outer surface of the protective tip and an outer surface of the cap or projection, within the fluid reservoir and extends between an internal surface of the protective tip and an outer surface of the projection, or within the sleeve and connected to a distal end of the protective tip.
  • the fluid-tight film seal is peelable or breakable.
  • the fluid-tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection.
  • a second fluid-tight film seal is positioned within the fluid reservoir and extends between the internal surface of the protective tip and the outer surface of the projection.
  • the fluid-tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection.
  • a second fluid-tight film seal is positioned within the sleeve and is connected to the distal end of the protective tip.
  • the fluid-tight film seal is positioned within the fluid reservoir and extends between the internal surface of the protective tip and the outer surface of the projection.
  • a second fluid-tight film seal is positioned within the sleeve and is connected to the distal end of the protective tip.
  • the fluid-tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection.
  • a second fluid-tight film seal is positioned within the fluid reservoir and extends between the internal surface of the protective tip and the outer surface of the projection.
  • a third fluid-tight film seal is positioned within the sleeve and is connected to the distal end of the protective tip.
  • the fluid-tight film seal is positioned within the sleeve, connected to a distal end of the protective tip, and formed of a water- soluble material.
  • the sleeve includes a constriction configured to reduce the space between the sleeve and the catheter.
  • the sleeve has opposing faces, with the constriction being defined by a heat seal between the opposing faces of the sleeve.
  • the sleeve includes a second constriction configured to reduce the space between the sleeve and the catheter.
  • an absorbent insert is positioned within the sleeve.
  • a second absorbent insert is positioned within the sleeve.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

A catheter assembly (10) includes a catheter (12) at least partially positioned within a sleeve (14). The catheter has a coating, which produces a low-friction surface on the catheter when treated with an activating fluid. A protective tip (16) is connected to the proximal end (18) of the sleeve (14) and has proximal (28) and distal (30) internal seals, with the proximal seal (28) at the proximal end (24) of the tip (16) or between proximal (24) and distal (22) ends of the protective tip (16). A cap (32) of the assembly has a projection (34), which is removably received within the protective tip (16) for sealing engagement with the proximal (28) and distal (30) seals to define a fluid reservoir (38) within the protective tip (16). An activating fluid is contained within the fluid reservoir (38). The projection (34) may be partially hollow to receive a portion of the catheter (12). The sleeve (14) may be relatively narrow or at least have a narrowed portion for better distribution of activating fluid to the surface of the catheter.

Description

URINARY CATHETER PROTECTIVE TIPS HAVING A FLUID RESERVOIR RELATED APPLICATION
This application claims the benefit of and priority of U.S. Provisional Patent Application Serial No. 61 /91 1 ,535, filed December 4, 2013, the contents of which are incorporated by reference herein.
DESCRIPTION
TECHNICAL FIELD
The present disclosure generally relates to urinary catheters. More particularly, the present disclosure relates to urinary catheters provided with a protective tip having a fluid reservoir.
BACKGROUND
Intermittent catheterization is a good option for many users who suffer from various abnormalities and pathologies of the urinary system and its nerve supply. Such catheters are typically provided as single use, individually packaged items and may include a gel-lubricant or hydrophilic coating as a lubricant for reducing friction during insertion into the urethra.
Regarding gel-coated catheters, a user applies a gel-lubricant, such as a water-based gel-lubricant, to the surface of the catheter, which reduces friction for ease of insertion into the urethra. In some instances, the gel-lubricant is supplied with the packaged catheter, in which case the gel-lubricant may be applied to the catheter surface just before or during the packaging operation or as the catheter is being inserted by the user.
When a hydrophilic material is used as a lubricant, a thin coating of hydrophilic material is applied to the outer surface of the catheter, and may subsequently be radiation- or heat-cured. When this coating is activated by swelling in contact with a hydrating liquid or wetting agent such as water, it provides a hydrated surface having an extremely low coefficient of friction. One form of this product provides a sterile, individually packaged, single-use catheter in a dry state or condition. The user opens the package, pours water into the package, waits 30 seconds, and then removes the catheter from the package, which is now ready for insertion. Other embodiments provide the amount of wetting agent necessary for immersion of the catheter in a separate compartment of the package. In such embodiments, the user must open the separate compartment of the package to allow the wetting agent to enter the catheter- containing chamber for direct contact with the hydrophilic coated surface. The catheter is then removed from the package and inserted into the urethra. In yet another embodiment, the ready-to-use catheter is provided in a package that already contains enough loose wetting agent to cause it to be immersed. In such an embodiment, the user simply opens the package and removes the catheter therefrom, and then inserts the catheter into the urethra, without the need to add the wetting agent.
A disadvantage of the hydrophilic coated catheters described above is that the immersion liquid has a tendency to spill from the package as the user handles the catheter and tries to remove it for subsequent insertion.
SUMMARY
There are several aspects of the present subject matter which may be embodied separately or together in the devices and systems described and claimed below. These aspects may be employed alone or in combination with other aspects of the subject matter described herein, and the description of these aspects together is not intended to preclude the use of these aspects separately or the claiming of such aspects separately or in different combinations as set forth in the claims appended hereto.
In one aspect, a catheter assembly includes a sleeve, with a catheter at least partially positioned within the sleeve. The catheter has a coating on at least a part of its length, which produces a low-friction surface on the catheter when treated with an activating substance. A protective tip is connected to the sleeve and has proximal and distal internal seals, with the proximal seal positioned at the proximal end of the protective tip or between proximal and distal ends of the protective tip. A cap has a projection removably received within the protective tip for sealing engagement with the proximal and distal seals to define a fluid reservoir within the protective tip. An activating fluid is contained within the fluid reservoir.
In another aspect, a catheter assembly includes a sleeve, with a catheter at least partially positioned within the sleeve. The catheter has a coating on at least a part of its length, which produces a low-friction surface on the catheter when treated with an activating substance. A protective tip is connected to the sleeve and defines a fluid reservoir, with an activating fluid contained therein. A cap has a projection removably received within the protective tip. The catheter assembly also includes at least one fluid-tight film seal, with the film seal being positioned outside of the protective tip and extending between an outer surface of the protective tip and an outer surface of the cap or projection, within the fluid reservoir and extending between an internal surface of the protective tip and an outer surface of the projection, or within the sleeve and connected to a distal end of the protective tip. BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a cross-sectional view of a proximal portion of an embodiment of a catheter assembly according to an aspect of the present disclosure;
Fig. 2 is a side elevational view of the proximal portion of the catheter assembly of Fig. 1 ;
Fig. 3 is a side elevational view of the proximal portion of the catheter assembly of Fig. 1 , with a cap of the catheter assembly partially removed from a protective tip of the catheter assembly;
Fig. 4 is a side elevational view of the proximal portion of the catheter assembly of Fig. 1 , with a cap of the catheter assembly fully removed from a protective tip of the catheter assembly;
Fig. 5 is a side elevational view of the catheter assembly of Fig. 1 ;
Fig. 6 is a cross-sectional view of a proximal portion of another
embodiment of a catheter assembly according to an aspect of the present disclosure;
Fig. 7 is a cross-sectional view of a proximal portion of yet another embodiment of a catheter assembly according to an aspect of the present disclosure;
Fig. 8 is a cross-sectional view of a proximal portion of another embodiment of a catheter assembly according to an aspect of the present disclosure;
Fig. 9 is a cross-sectional view of a proximal portion of yet another embodiment of a catheter assembly according to an aspect of the present disclosure;
Fig. 10 is a side elevational view of a catheter assembly incorporating an alternative sleeve according to an aspect of the present disclosure; and
Fig. 1 1 is a side elevational view of a catheter assembly incorporating another alternative sleeve according to an aspect of the present disclosure.
DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS
The embodiments disclosed herein are for the purpose of providing a description of the present subject matter, and it is understood that the subject matter may be embodied in various other forms and combinations not shown in detail. Therefore, specific embodiments and features disclosed herein are not to be interpreted as limiting the subject matter as defined in the accompanying claims.
Figs. 1 and 2 illustrate an embodiment of a catheter assembly 1 0, such as a urinary catheter assembly. The catheter assembly 10 may be variously configured without departing from the scope of the present disclosure, but in one embodiment, the catheter assembly 10 includes a catheter 12 (such as a urinary catheter) at least partially positioned within a sleeve 14, which may be defined by a flexible polymeric material (such as, but not limited to, polyurethane) wrapped about the catheter 12. A protective tip 16 is secured or connected to a proximal end 18 of the sleeve 14, with an opposite or distal end 20 of the sleeve 14 (Fig. 5) being sealed or otherwise closed to define a sealed container for the catheter 16.
The protective tip 16 extends between a distal end 22 and a proximal end 24. The protective tip 16 is sealingly connected or secured to the sleeve 14 at or adjacent to the distal end 22 of the protective tip 1 6. The proximal end 24 of the protective tip 1 6 may include an aperture or opening 26 that may be moved between a closed configuration (in which the catheter 12 is fully positioned within the sleeve 14 and protective tip 1 6 and there is no other object positioned within the opening 26) and an open configuration (in which the catheter 12 or any other object is partially positioned within or extending through the opening 26, with a portion of the object positioned within the protective tip 16 and another portion positioned outside of the protective tip 16). In one embodiment, the opening 26 is provided as a slit opening with one or more slits or cuts defining a plurality of deformable petals that may be moved to define the aforementioned open and closed configurations. In other embodiments, the opening may be differently configured, provided that it is configured to allow passage of the catheter therethrough. As will be described in greater detail below, the protective tip 16 may include an internal proximal seal or sealing surface or sealing member 28 and an internal distal seal or sealing surface or sealing member 30 (Fig. 1 ), with the seals 28 and 30 being spaced from each other and at least the proximal seal 28 positioned between the proximal and distal ends 24 and 22 of the protective tip 16.
The catheter assembly 10 may further include a cap 32 configured to be removably connected to the protective tip 16. As shown in Fig. 1 , the cap 32 may be connected to a proximal portion of the protective tip 16 so as to form a substantially fluid- or water-tight seal, which encloses the opening 26 at the proximal end 24 of the protective tip 16. In the illustrated embodiment, the cap 32 includes a projection or extension or plug 34, which is shown as being elongated along a central axis of the cap 32. While the projection 34 is illustrated as having a solid, substantially cylindrical configuration with a substantially uniform outer diameter, it is also within the scope of the present disclosure for the projection 34 to be differently configured (e.g., non-cylindrical).
When the cap 32 has been mounted onto the protective tip 16, the projection 34 is at least partially positioned within the protective tip 16, as shown in Fig. 1 . The projection 34 extends through the proximal opening 26 of the protective tip 1 6 (with the projection 34 holding the opening 26 in an at least partially open configuration) to sealingly cooperate with the protective tip 16 (or a component thereof) to provide the proximal and distal seals 28 and 30. Hence, it can be seen that the projection 34 engages the protective tip 16 (or a component thereof) in at least three locations: at the proximal opening 26, at the proximal seal 28, and at the distal seal 30. It may be preferred for the projection 34 to have a relatively small outer diameter at the portion which is positioned within the proximal opening 26 of the protective tip 1 6 in order to prevent tip deformation or shape-setting during storage of the catheter assembly 1 0.
As noted above, the projection 34 sealingly engages the proximal and distal seals 28 and 30 of the protective tip 16, thereby defining a fluid- or water- tight seal at each of the internal seals 28 and 30. The seals 28 and 30 are each configured to press against the outer surface of the projection 34, thereby forming a complete seal around an outer perimeter of the projection 34. To form such a fluid- or water-tight seal, each seal 28, 30 may be configured to define an opening or aperture with a cross-sectional shape that is comparable to the cross-sectional shape of the projection 34. For example, if the projection 34 is substantially cylindrical (as in the illustrated embodiment), with a substantially circular cross- sectional shape, each of the internal seals 28, 30 may substantially annular to define a central circular opening or aperture. In other embodiments, if the cross- sectional shape of the projection 34 is non-circular, one or both of the internal seals 28 and 30 may be configured to define openings or apertures which are similarly non-circularly configured to match the cross-sectional shape of the projection 34.
It may be preferred for the openings or apertures defined by the internal seals 28 and 30 to be slightly smaller than the portion of the projection 34 which is positioned within the opening or aperture when the cap 32 has been mounted onto the protective tip 16. Such a configuration may be preferred in order to promote a fluid- or water-tight seal at each internal seal 28, 30, but it is also within the scope of the present disclosure for the openings or apertures defined by the internal seals 28 and 30 to have a size and shape substantially identical to that of the corresponding portion of the projection 34. If one or both of the internal seals 28 and 30 is configured to define an opening or aperture slightly smaller than the corresponding portion of the projection 34, it may be advantageous for that seal or those seals to be formed of a deformable material to allow the seal to deform outwardly to accommodate the larger cross-section of the projection 34. For example, in one embodiment, the internal seals 28 and 30 of the protective tip 1 6 may be formed of an elastomeric material (e.g., an O-ring), which provides a fluid- or water-tight seal while being deformable. In other embodiments, different materials such as silicone; the polyether block amide material marketed as PEBAX® by Arkema S.A. of Colombes, France; thermoplastic polyurethanes; thermoplastic elastomers; thermoplastic polyolefins; and the like may be used. It is also within the scope of the present disclosure for the proximal seal 28 to be formed of a different material than the distal seal 30.
The proximal and distal internal seals 28 and 30 may be inner surfaces of the protective tip 16 or may be directly connected to the inner surface of the protective tip 1 6 or may be connected to the inner surface of the protective tip 16 via an intermediate member. For example, in the illustrated embodiment, the inner surface of the protective tip 1 6 has a greater diameter at its distal end 22 than at its proximal end 24. In such an embodiment, it may be advantageous for a grommet or spacer or intermediate member 36 to be connected to the inner surface of the protective tip 16 (Fig. 1 ), with the grommet 36 defining an opening or aperture in which the distal seal 30 may be formed. By providing a grommet 36, the distal seal 30 may be positioned closer to the central axis of the protective tip 1 6 without increasing the size of the distal seal 30. Alternatively, the grommet 36 itself (as a component of the protective tip 16) may provide an internal seal or sealing surface which sealingly engages the projection 34. The material composition of the grommet 36 may vary without departing from the scope of the present disclosure, but in one embodiment, the grommet 36 is a generally annular member comprised of a generally rigid or semi-rigid material having a relatively low water permeability. For example, the grommet 36 may be made from a thermoplastic elastomer, such as a non-swellable polyolefin material or PEBAX® or the like.
With the cap 32 mounted upon the protective tip 16, the projection 34 forms fluid- or water-tight seals at each internal seal 28, 30. By such a configuration, a fluid reservoir or compartment 38 is defined between the internal seals 28 and 30 of the protective tip 16 (Fig. 1 ). An activating or hydrating fluid may be contained within the fluid reservoir 38, which fluid is configured to interact with a coating (such as, but not limited to, a hydrophilic coating) on the catheter 12 to provide a lubricious surface to the catheter 12. The nature of the activating fluid may vary depending on the nature of the coating on the catheter 12 but, in one
embodiment, the activating fluid is water. The fluid reservoir 38 is at least partially filled with the activating fluid during manufacture (e.g., between 2 and 5 ml of activating fluid) and remains within the fluid reservoir 38 during storage and until the catheter assembly 10 is used, as described below. The fluid reservoir 38 may be filled with the activating fluid by any suitable method, but in one embodiment, the activating fluid may be dispensed into the fluid reservoir 38 while only one of the seals 28 and 30 is in place. In another embodiment, activating fluid in a container (e.g., a water-soluble polymer pouch or container) may be inserted into the fluid reservoir 38, with the container being dissolved (in the case of a water- soluble container) or otherwise manipulated or processed to release the activating fluid into the fluid reservoir 38 after the fluid reservoir 38 has been sealed. Other methods of dispensing activating fluid into the fluid reservoir 38 may be employed without departing from the scope of the present disclosure.
As the fluid reservoir 38 is intended to house the activating fluid during storage of the catheter assembly 10, it may be preferred for the protective tip 1 6 (or at least the portion defining the fluid reservoir 38) to be formed of a rigid or semi-rigid material having a relatively low water permeability (e.g., polyethylene). Similarly, the projection 34 of the cap 32 is intended to be at least partially positioned within the fluid reservoir 38 during storage of the catheter assembly 10, so it may be advantageous for the cap 32 (or at least the projection 34) to be formed of a rigid or semi-rigid material having a relatively low water permeability. In one embodiment, the fluid reservoir 38 and the projection 34 are formed of the same material, which may also be the same material as is used to form the grommet 36, but in other embodiments, the fluid reservoir 38, the projection 34, and the grommet 36 may be formed of different materials.
In use, the catheter assembly 10 is provided to a user in the configuration shown in Figs. 1 and 2. In one embodiment, the catheter assembly 10 may be enclosed within a sealed package or container (not illustrated) that must be opened by the user prior to use of the catheter assembly 1 0. In other
embodiments, the cap 32 and sleeve 14 serve as a sealed package for the catheter 12. When the catheter assembly 10 has been removed from the package (if provided), the user partially withdraws the cap 32 from the protective tip 1 6 (Fig. 3) so as to disengage the projection 34 from the distal internal seal 30. By so disengaging the projection 34 from the distal internal seal 30, the activating fluid is allowed to flow out of the fluid reservoir 38 and into the sleeve 14 via the opening or aperture defined by the distal seal 30. It may be advantageous for the catheter assembly 10 to be held vertically by the user, with the cap 32 and protective tip 1 6 pointing upwardly, to promote flow of the activating fluid out of the fluid reservoir 38 and into the sleeve 14. By only partially removing the cap 32 from the protective tip 16, the projection 34 maintains the proximal internal seal 28, thereby preventing the activating fluid from flowing out of the proximal opening 26 of the protective tip 16.
Alternatively, rather than only partially removing the cap 32 from the protective tip 1 6, the user may completely remove the cap 32 from the protective tip 1 6 to allow the activating fluid to flow from the fluid reservoir 38 into the sleeve 14. Although there is no proximal internal seal 28 maintained by the projection 34, the proximal opening 26 of the protective tip 16 (in a closed configuration) may provide a fluid- or water-tight seal to prevent the activating fluid from flowing out of the catheter assembly 10.
The activating fluid contacts the hydrophilic coating of the catheter 1 2 and interacts therewith to form a lubricious coating on the catheter 12. The sleeve 14 is preferably formed of a substantially transparent or translucent material to allow the user to visually confirm that the activating fluid has covered the catheter 12 along the length of the coating. It may also be advantageous for the sleeve 14 to be formed of a flexible material to allow the user to manipulate the catheter 12 through the sleeve 14 to better apply the activating fluid to the coating of the catheter 12. In one embodiment, the sleeve 14 is formed of a soft, hydrophilic material, such as a polyurethane film, although other thin, soft film materials (either vapor permeable or impermeable) may also be used without departing from the scope of the present disclosure.
After the catheter 12 has been treated with the activating fluid, the cap 32 may be fully removed from the protective tip 16 (if it has only been partially withdrawn from the protective tip 16), as in Fig. 4, which moves the proximal opening 26 to its closed configuration. Thereafter, the lubricated catheter 1 2 may be advanced proximally into and through the protective tip 16 to exit the protective tip 1 6 via the proximal opening 26. If the catheter assembly 1 0 is provided as a urinary catheter assembly, the proximal end 24 (including the proximal opening 26) of the protective tip 16 may be positioned within the urethra prior to advancing the catheter 12 out of the proximal opening 26 of the protective tip 1 6. With the proximal end 24 of the protective tip 16 in the urethra, the proximal end of the catheter 12 may be advanced out of the proximal opening 26 of the protective tip 16 and through the urethra until the proximal end of the catheter 12 reaches the bladder. Urine within the bladder flows into the open interior of the catheter 12 via one or more eyes or openings 40 of the catheter 12 (Fig. 1 ), where it then flows through the catheter 12 and into the sleeve 14. More preferably, rather than allowing urine to flow into the sleeve 14, the distal end of the catheter 12 may include a funnel or drainage device 42 (Fig. 5) that allows urine to drain out of the catheter 12 and into a toilet or other waste receptacle. Thereafter, the catheter 12 may be removed from the urethra, with the catheter assembly 1 0 and urine being discarded after use.
Fig. 6 illustrates an alternative embodiment of a catheter assembly 10a according to the present disclosure. The embodiment of Fig. 6 is similar to the catheter assembly 10 of Figs. 1 -5, with some differences in the configurations of the protective tip 16a and the cap 32a. In the embodiment of Fig. 6, the protective tip 1 6a has a generally slimmer configuration than the protective tip 16 of Figs. 1 - 5, with the distal end 22a of the protective tip 16a having a diameter that is larger than that of the proximal end 24a, but with the diameters being more similarly sized than in the embodiment of Figs. 1 -5. As in the embodiment of Figs. 1 -5, the distal seal 30 is provided at a grommet or spacer 36a, with the proximal seal 28 being provided at an inner surface of the protective tip 1 6a. However, it should be understood that the configurations of the internal seals 28 and 30 may vary, as described above with regard to the embodiment of Figs. 1 -5.
As for the cap 32a, it varies from the cap 32 of Figs. 1 -5 in that its projection 34a defines a hollow portion or cavity 44 at a distal portion of the projection 34a. By such a configuration, a proximal end or portion of the catheter 12 may be positioned within the hollow portion 44 of the projection 34a during storage of the catheter assembly 10a, prior to use. Such a configuration may be advantageous in that a shorter sleeve 14a may be employed, thereby decreasing the material cost of the catheter assembly 10a and the storage space required.
It will be seen that the catheter 12 has a smaller diameter than the distal seal 30 in the embodiment of Fig. 6, such that removing the cap 32a results in a gap or separation between the catheter 1 2 and the distal seal 30. This separation between the catheter 12 and the distal seal 30 allows activating fluid to flow out of the protective tip 16a and into the sleeve 14a when the cap 32a (and, hence, the projection 34a) has been removed, thereby hydrating the portion of the catheter 12 positioned within the sleeve 14a.
Fig. 7 illustrates a variation of the embodiment of Fig. 6. The catheter assembly 10b of Fig. 7 is substantially identical to the embodiment of Fig. 6, except that it is provided with an additional or third or auxiliary seal or flow-limiting feature 46. In the illustrated embodiment, the third seal 46 is positioned distally of the distal seal 30, at or adjacent to the distal end 22a of the protective tip 16a (i.e., outside and distally of the fluid reservoir 38). The third seal 46 is configured to bear against the catheter 12, thereby forming either a fluid- or water-tight seal therewith or providing a flow-limiting feature. The third seal 46, when providing a fluid- or water-tight seal, helps to maintain the activating fluid within the fluid reservoir 38 after the cap 32a is removed from the protective tip 16a by preventing the activating fluid from flowing into the sleeve 14a. By such a configuration, the activating fluid remains within the fluid reservoir 38, such that the catheter 1 2 (and the coating thereof) comes into contact with the activating fluid as the catheter 12 is advanced proximally through and out of the protective tip 16a, rather than the activating fluid contacting the coating within the sleeve 14a. On the other hand, if the third seal 46 is configured to provide a flow-limiting feature, at least a portion of the third seal 46 may be spaced away or separated from the outer surface of the catheter 12 to allow a regulated or limited flow of activating fluid into the sleeve 14a when the cap 32a is removed (as in the embodiment of Fig. 6).
The material composition of the third seal 46 may vary without departing from the scope of the present disclosure, but in one embodiment, the third seal 46 is formed of the same material as one or both of the other seals 28 and 30. In other embodiments, the third seal 46 may be formed of a different material than the other seals 28 and 30. Suitable materials for the third seal 46 include, but are not limited to, elastomeric materials, silicone, PEBAX®, thermoplastic
polyurethanes, thermoplastic elastomers, thermoplastic polyolefins, and other non-woven fabric materials.
Fig. 8 illustrates yet another embodiment of a catheter assembly 10c according to the present disclosure. The catheter assembly 10c of Fig. 8 is comparable to the embodiment of Figs. 1 -5, except that it further includes a sponge or absorbent member 48 associated with the protective tip 16 to bear against the catheter 12. In the illustrated embodiment, the absorbent member 48 has a generally annular configuration and is associated with the grommet 36, seated within a counterbore or pocket or cavity 50 at a distal side or end of the grommet 36 (i.e., outside and distally of the fluid reservoir 38). By such a configuration, the absorbent member 48 absorbs and retains a portion of the activating fluid as it flows out of the fluid reservoir 38 and into the sleeve 14. As the catheter 12 is advanced proximally through the protective tip 16, it presses against the absorbent member 48, with the absorbent member 48 applying some of the retained activating fluid to the surface (and, hence, the hydrophilic coating) of the catheter 12. This helps to ensure that activated fluid is applied to the entirety of the coated portion of the catheter 1 2 as the catheter 1 2 is advanced out of the protective tip 16. The material composition of the absorbent member 48 may vary without departing from the scope of the present disclosure but, in one embodiment, the absorbent member 48 is formed of a sponge- or foam-like material, such as an open-cell sponge or foam material from foamed polymers (e.g., polyethylene or polyurethane or polyvinyl chloride) or the like.
Fig. 9 illustrates an alternative seal configuration. In the catheter assembly
10d of Fig. 9, the projection 34d of the cap 32d is spaced away from the protective tip 1 6d at the proximal end 24d of the protective tip 16d. A proximal fluid-tight seal is provided between the protective tip 16d and the cap 32d by a fluid-tight film that is sealed to the two components, such as by heat seals. In one embodiment, one or both of the heat seals may be a peelable or breakable, as will be described in greater detail. In the embodiment of Fig. 9, three fluid-tight films 52a, 52b, and 52c are provided, with a distal film 52c providing a distal seal, but it is within the scope of the present disclosure for the catheter assembly 10d to include only one or two such films. For example, the fluid-tight film seal or seals may be configured to provide only a proximal seal, only a distal seal, or both a proximal seal and a distal seal for the fluid reservoir 38.
One of the illustrated films 52a is provided within the protective tip 1 6d, at or adjacent to the proximal end 24d of the protective tip 16d. The film 52a extends from the inner surface of the protective tip 1 6d to the outer surface of the cap projection 34d, being connected (e.g., by heat seals) to each component. Another illustrated film 52b is positioned outside of the protective tip 16d, at or adjacent to the proximal end 24d of the protective tip 1 6d. The second film 52b extends from the outer surface of the protective tip 16d to the outer surface of the cap 32d (or a portion of the projection 34d positioned outside of the protective tip 16d) and is connected (e.g., by heat seals) to each component. The third illustrated film 52c is positioned within the sleeve 14 and is connected (e.g., by a heat seal) to the distal end 22d of the protective tip 16d and/or the grommet 36a of the protective tip 16d, overlaying the opening through which the catheter 12 may be advanced into the fluid reservoir 38. The third film 52c may also be connected (e.g., by a heat seal) to the distal end of the cap projection 34d.
In use, the cap 32d is moved proximally with respect to the protective tip 16d, thereby removing any slack in the films 52a, 52b, and 52c. The slack in the proximal films 52a and 52b allows the projection 34d to separate from the distal seal 30 while the proximal seals provided by the films 52a and 52b remain intact. Preferably, the distal seal provided by the film 52c is broken before the proximal seals are broken, such that the activating fluid flows out of the fluid reservoir 38 (though the opening formerly sealed by the distal film 52c) and into the sleeve 14 to interact with the coating on the catheter 12. In one embodiment, the distal film 52c is connected to the distal end of the cap projection 34d and configured to break or detach from the protective tip 16d or grommet 36a upon sufficient proximal movement of the cap 32d. In another embodiment, the distal film 52c may be configured to be broken by proximal movement of the catheter 12 into contact with the film 52c. In yet another embodiment, the distal film 52c may be configured to dissolve over time (e.g., if the film 52c is formed of a water-soluble material), which allows the activating fluid to be released into the sleeve 14 during storage of the catheter assembly 10d for hydration of the catheter 1 2 over an extended period of time. Alternatively, the distal film 52c may be configured to only weaken over time, without dissolving, thereby preventing activating fluid from entering the sleeve 14, while also making it easier for a user to break the distal seal.
Depending on the nature of the proximal films 52a and 52b, they may either break upon application of sufficient force or may be peeled off to separate them from one or both of the associated components of the catheter assembly 10d. Breaking/peeling the heat seals of the films 52a and 52b allows for the cap 32d to be fully removed and separated from the protective tip 16d. In one embodiment, the film 52a positioned within the protective tip 16d may be configured to dissolve or weaken over time (e.g., if the film 52a is formed of a water-soluble material), which makes it easier for a user to break the seal and remove the cap 32d immediately prior to use.
Figs. 10 and 1 1 illustrate catheter assemblies 10e and 10f having alternatively configured sleeves 14e and 14f. The illustrated sleeves 14e and 14f are configured to slow the rate at which activating fluid flows through the sleeve and to extend the time that the activating fluid is in contact with all coated areas of the catheter 12. Either of the sleeves 14e and 14f may be used in combination with any of the catheter assemblies described herein or with other catheter assemblies in which an activating fluid flows through a catheter-containing sleeve.
In the embodiment of Fig. 1 0, the sleeve 14e is provided with a plurality of constrictions 54, but may have as few as one constriction 54. The constrictions 54 effectively decrease the size of the gap between the sleeve 14e and the catheter 12, thereby preventing the activating fluid from quickly flowing through the sleeve 14e. As the activating fluid flows through the sleeve 14e, it is funneled through the relatively small opening defined by each constriction 54, which causes the activating fluid to remain upstream of each constriction 54 for a longer amount of time, in contact with the coating on the catheter 12. The exact flow rate of the activating fluid through the sleeve 14e and through the opening defined by each constriction 54 may be varied by adjusting the configuration of each constriction 54 (e.g., by increasing or decreasing the size of the opening defined by a constriction 54). The constrictions 54 may be formed by any suitable method, but in one embodiment are formed by a heat sealing procedure that seals together opposing faces of the sleeve 14e.
In the embodiment of Fig. 1 1 , the sleeve 14f is provided with a plurality of absorbent inserts 56, but may have as few as one absorbent insert 56. The absorbent inserts 54 absorb a portion of the activating fluid as it flows through the sleeve 14f. As the catheter 12 is advanced proximally out of the sleeve 14f, it brushes against the absorbent inserts 54, which transfer activating fluid to the coating of the catheter 12 (similar to the action of the absorbent member 48 of Fig. 8). The sleeve 14f may be squeezed at the absorbent inserts 56 to transfer additional amounts of activating fluid from the absorbent inserts 56 to the catheter 12. The configuration of the absorbent inserts 56 may vary, but it may be advantageous for them to be substantially annular and formed from a sponge- or foam-like non-woven fabric material, such as an open-cell sponge or foam material from foamed polymers (e.g., polyethylene or polyurethane or polyvinyl chloride) or the like. The absorbent inserts 56 may be sealed or secured to the sleeve 14f by any suitable means, which may vary according to the material composition of the absorbent inserts 56 and the sleeve 14f.
It should be understood that the methods described herein are merely exemplary, and that the steps described above may be carried out in a different order. Further, other steps may be included when using the devices described herein. Additionally, one or more of the steps described herein in connection with the methods may be omitted or modified without departing from the scope of the present disclosure. Similarly, the systems described herein are merely
exemplary, and they may be differently configured (e.g., by combining one or more components of one described embodiment with one or more components of another described embodiment) without departing from the scope of the present disclosure.
Aspects of the present subject matter described above may be beneficial alone or in combination with one or more other aspects. Without limiting the foregoing description, in accordance with one aspect of the subject matter herein, there is provided a catheter assembly, which includes a sleeve with a catheter at least partially positioned therein. There is a coating on at least a part of the catheter which produces a low-friction surface on the catheter when treated with an activating fluid. A protective tip is connected to the sleeve and has proximal and distal internal seals, with the proximal seal being positioned at a proximal end of the protective tip or between proximal and distal ends of the protective tip. A cap includes a projection removably received within the protective tip for sealing engagement with the proximal and distal seals to define a fluid reservoir within the protective tip, with an activating fluid contained within the fluid reservoir. In accordance with another aspect which may be used or combined with the first aspect, the projection has a substantially uniform outer diameter.
In accordance with another aspect which may be used or combined with the any of the preceding aspects, at least one of the internal seals is formed of a deformable material.
In accordance with another aspect which may be used or combined with the any of the preceding aspects, a grommet is secured to an inner surface of the protective tip, with the grommet defining an opening in which the distal internal seal is positioned.
In accordance with another aspect which may be used or combined with the fourth aspect, a distal side of the grommet defines a pocket, with a generally annular absorbent member at least partially positioned within the pocket.
In accordance with another aspect which may be used or combined with any of the preceding aspects, a distal portion of the projection defines a cavity in which a proximal end of the catheter is positionable.
In accordance with another aspect which may be used or combined with the preceding aspect, a third internal seal is positioned distally of the distal internal seal, with the third internal seal being configured to bear against the catheter.
In accordance with another aspect which may be used or combined with the sixth aspect, a third internal seal is positioned distally of the distal internal seal, with at least a portion of the third internal seal being separated from the catheter to provide a flow-limiting arrangement.
In accordance with another aspect, there is provided a catheter assembly, which includes a sleeve with a catheter at least partially positioned therein. There is a coating on at least a part of the catheter which produces a low-friction surface on the catheter when treated with an activating fluid. A protective tip is connected to the sleeve and defines a fluid reservoir, which contains an activating fluid. A cap includes a projection removably received within the protective tip. At least one fluid-tight film seal is positioned outside of the protective tip and extends between an outer surface of the protective tip and an outer surface of the cap or projection, within the fluid reservoir and extends between an internal surface of the protective tip and an outer surface of the projection, or within the sleeve and connected to a distal end of the protective tip. In accordance with another aspect which may be used or combined with the preceding aspect, the fluid-tight film seal is peelable or breakable.
In accordance with another aspect which may be used or combined with any of the preceding two aspects, the fluid-tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection. A second fluid-tight film seal is positioned within the fluid reservoir and extends between the internal surface of the protective tip and the outer surface of the projection.
In accordance with another aspect which may be used or combined with any of the ninth through tenth aspects, the fluid-tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection. A second fluid-tight film seal is positioned within the sleeve and is connected to the distal end of the protective tip.
In accordance with another aspect which may be used or combined with any of the ninth through tenth aspects, the fluid-tight film seal is positioned within the fluid reservoir and extends between the internal surface of the protective tip and the outer surface of the projection. A second fluid-tight film seal is positioned within the sleeve and is connected to the distal end of the protective tip.
In accordance with another aspect which may be used or combined with any of the ninth through tenth aspects, the fluid-tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection. A second fluid-tight film seal is positioned within the fluid reservoir and extends between the internal surface of the protective tip and the outer surface of the projection. A third fluid-tight film seal is positioned within the sleeve and is connected to the distal end of the protective tip.
In accordance with another aspect which may be used or combined with any of the ninth through tenth aspects, the fluid-tight film seal is positioned within the sleeve, connected to a distal end of the protective tip, and formed of a water- soluble material.
In accordance with another aspect which may be used or combined with any of the preceding aspects, the sleeve includes a constriction configured to reduce the space between the sleeve and the catheter. In accordance with another aspect which may be used or combined with the preceding aspect, the sleeve has opposing faces, with the constriction being defined by a heat seal between the opposing faces of the sleeve.
In accordance with another aspect which may be used or combined with any of the preceding two aspects, the sleeve includes a second constriction configured to reduce the space between the sleeve and the catheter.
In accordance with another aspect which may be used or combined with any of the first through fifteenth aspects, an absorbent insert is positioned within the sleeve.
In accordance with another aspect which may be used or combined with the preceding aspect, a second absorbent insert is positioned within the sleeve.
It will be understood that the embodiments described above are illustrative of some of the applications of the principles of the present subject matter.
Numerous modifications may be made by those skilled in the art without departing from the spirit and scope of the claimed subject matter, including those combinations of features that are individually disclosed or claimed herein. For these reasons, the scope hereof is not limited to the above description but is as set forth in the following claims, and it is understood that claims may be directed to the features hereof, including as combinations of features that are individually disclosed or claimed herein.

Claims

1 . A catheter assembly, comprising:
a sleeve;
a catheter at least partially positioned within the sleeve and having a coating on at least a part of its length which produces a low-friction surface on the catheter when treated with an activating fluid;
a protective tip connected to the sleeve and having proximal and distal internal seals, with the proximal seal positioned at a proximal end of the protective tip or between proximal and distal ends of the protective tip;
a cap including a projection removably received within the protective tip for sealing engagement with the proximal and distal seals to define a fluid reservoir within the protective tip; and
an activating fluid contained within the fluid reservoir.
2. The catheter assembly of claim 1 , wherein the projection has a
substantially uniform outer diameter.
3. The catheter assembly of any of the preceding claims, wherein at least one of the internal seals is formed of a deformable material.
4. The catheter assembly of any of the preceding claims, further comprising a grommet secured to an inner surface of the protective tip, wherein the grommet defines an opening in which the distal internal seal is positioned.
5. The catheter assembly of claim 4, wherein
a distal side of the grommet defines a pocket, and
a generally annular absorbent member is at least partially positioned within the pocket.
6. The catheter assembly of any of the preceding claims, wherein a distal portion of the projection defines a cavity in which a proximal end of the catheter is positionable.
7. The catheter assembly of claim 6, further comprising a third internal seal positioned distally of the distal internal seal, wherein the third internal seal is configured to bear against the catheter.
8. The catheter assembly of claim 6, further comprising a third internal seal positioned distally of the distal internal seal, wherein at least a portion of the third internal seal is separated from the catheter to provide a flow-limiting arrangement.
9. A catheter assembly, comprising:
a sleeve;
a catheter at least partially positioned within the sleeve and having a coating on at least a part of its length which produces a low-friction surface on the catheter when treated with an activating fluid;
a protective tip connected to the sleeve and defining a fluid reservoir;
a cap having a projection removably received within the protective tip; an activating fluid contained within the fluid reservoir; and
at least one fluid-tight film seal, wherein the at least one fluid-tight film seal is
positioned outside of the protective tip and extends between an outer surface of the protective tip and an outer surface of the cap or projection;
positioned within the fluid reservoir and extends between an internal surface of the protective tip and an outer surface of the projection; or
positioned within the sleeve and connected to a distal end of the protective tip.
10. The catheter assembly of claim 9, wherein the at least one fluid-tight film seal is peelable or breakable.
1 1 . The catheter assembly of any of claims 9-1 0, wherein the at least one fluid- tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection, and further comprising a second fluid-tight film seal positioned within the fluid reservoir and extending between the internal surface of the protective tip and the outer surface of the projection.
12. The catheter assembly of any of claims 9-1 0, wherein the at least one fluid- tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection, and further comprising a second fluid-tight film seal positioned within the sleeve and connected to the distal end of the protective tip.
13. The catheter assembly of any of claims 9-1 0, wherein the at least one fluid- tight film seal is positioned within the fluid reservoir and extends between the internal surface of the protective tip and the outer surface of the projection, and further comprising a second fluid-tight film seal positioned within the sleeve and connected to the distal end of the protective tip.
14. The catheter assembly of any of claims 9-1 0, wherein the at least one fluid- tight film seal is positioned outside of the protective tip and extends between the outer surface of the protective tip and the outer surface of the cap or projection, and further comprising
a second fluid-tight film seal positioned within the fluid reservoir and extending between the internal surface of the protective tip and the outer surface of the projection, and
a third fluid-tight film seal positioned within the sleeve and connected to the distal end of the protective tip.
15. The catheter assembly of any of claims 9-1 0, wherein the at least one fluid- tight film seal is positioned within the sleeve, connected to a distal end of the protective tip, and formed of a water-soluble material.
16. The catheter assembly of any of the preceding claims, wherein the sleeve includes a constriction configured to reduce the space between the sleeve and the catheter.
17. The catheter assembly of claim 16, wherein
the sleeve comprises opposing faces, and
the constriction is defined by a heat seal between the opposing faces of the sleeve.
18. The catheter assembly of any of claims 16-17, wherein the sleeve includes a second constriction configured to reduce the space between the sleeve and the catheter.
19. The catheter assembly of any of claims 1 -1 5, further comprising an absorbent insert positioned within the sleeve.
20. The catheter assembly of claim 19, further comprising a second absorbent insert positioned within the sleeve.
PCT/US2014/068299 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir WO2015084923A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA2923674A CA2923674C (en) 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir
LTEP14816051.8T LT3077031T (en) 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir
DK14816051.8T DK3077031T3 (en) 2013-12-04 2014-12-03 URINCATHETER PROTECTION TIPS WITH A FLUID RESERVOIR
US14/914,822 US10946172B2 (en) 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir
AU2014360561A AU2014360561B2 (en) 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir
EP14816051.8A EP3077031B1 (en) 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir
ES14816051T ES2841177T3 (en) 2013-12-04 2014-12-03 Protective urinary catheter tips with a fluid reservoir
US17/153,184 US11813412B2 (en) 2013-12-04 2021-01-20 Urinary catheter protective tips having a fluid reservoir
US18/484,006 US20240033478A1 (en) 2013-12-04 2023-10-10 Urinary catheter assemblies having a sleeve

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361911535P 2013-12-04 2013-12-04
US61/911,535 2013-12-04

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/914,822 A-371-Of-International US10946172B2 (en) 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir
US17/153,184 Division US11813412B2 (en) 2013-12-04 2021-01-20 Urinary catheter protective tips having a fluid reservoir

Publications (1)

Publication Number Publication Date
WO2015084923A1 true WO2015084923A1 (en) 2015-06-11

Family

ID=52134428

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/068299 WO2015084923A1 (en) 2013-12-04 2014-12-03 Urinary catheter protective tips having a fluid reservoir

Country Status (9)

Country Link
US (3) US10946172B2 (en)
EP (1) EP3077031B1 (en)
AU (1) AU2014360561B2 (en)
CA (1) CA2923674C (en)
DK (1) DK3077031T3 (en)
ES (1) ES2841177T3 (en)
HU (1) HUE053380T2 (en)
LT (1) LT3077031T (en)
WO (1) WO2015084923A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016204858A1 (en) * 2015-06-15 2016-12-22 Hollister Incorporated Urinary catheters having limited reusability
WO2019014344A1 (en) * 2017-07-12 2019-01-17 Hollister Incorporated Ready-to-use urinary catheter assembly
WO2019222644A1 (en) * 2018-05-17 2019-11-21 Hollister Incorporated Methods of making sleeved hydrophilic catheter assemblies
WO2022223982A1 (en) * 2021-04-23 2022-10-27 Convatec Limited Intermittent catheter
WO2024084202A3 (en) * 2022-10-19 2024-07-04 Convatec Limited A catheter assembly

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721955D0 (en) * 2017-12-27 2018-02-07 Convatec Ltd Catheter wetting devices
HUE066403T2 (en) * 2018-06-19 2024-07-28 Hollister Inc Female urinary catheter deployment devices and methods of using the same
CA3120635A1 (en) * 2018-11-21 2020-05-28 Hollister Incorporated Hydration solutions containing volatile solutes and medical device products including the same
US20210290894A1 (en) * 2020-03-23 2021-09-23 Cure Medical Llc Pre-lubricated female urinary catheter package
US20210299410A1 (en) * 2020-03-27 2021-09-30 Wiesconcepts, LLC Protective Sheath Assembly For A Method Of Evaluation And/Or Retrieving Pathological Samples From A Body Orifice, A Method For Administering An Anesthetic, Formulated Medication And/Or Chemotherapy Using A Protective Sheath Assembly
GB202006059D0 (en) * 2020-04-24 2020-06-10 Convatec Ltd A wetting mechanism for a catheter
GB202006055D0 (en) * 2020-04-24 2020-06-10 Convatec Ltd A wetting mechanism for a catheter
GB202006060D0 (en) * 2020-04-24 2020-06-10 Convatec Ltd A wetting mechanism for a catheter
US12053593B2 (en) 2020-04-24 2024-08-06 Convatec Limited Wetting mechanism for a catheter
GB202006056D0 (en) * 2020-04-24 2020-06-10 Convatec Ltd A catheter
WO2023180718A1 (en) * 2022-03-21 2023-09-28 Convatec Limited A catheter assembly
WO2023180725A1 (en) * 2022-03-21 2023-09-28 Convatec Limited A catheter assembly
WO2024194612A1 (en) * 2023-03-17 2024-09-26 Convatec Limited Intermittent catheter

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2319507A (en) * 1996-11-21 1998-05-27 Rusch Manufacturing Packaged catheter with lubricant-activating liquid
US20130079755A1 (en) * 2011-09-23 2013-03-28 Adapta Medical, Inc. Catheter Advancement
US20130079756A1 (en) * 2011-09-23 2013-03-28 Adapta Medical, Inc. Catheter Reservoir Seal

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1137086A (en) * 1913-02-13 1915-04-27 William Rodiger Collapsible tube.
US2849739A (en) * 1952-11-04 1958-09-02 A H Wirz Inc Sealing nitrocellulose cement
US3187966A (en) * 1963-07-09 1965-06-08 Continental Can Co Flexible container with snip-off and reseal features
US3421509A (en) * 1965-12-17 1969-01-14 John M Fiore Urethral catheter
US3640418A (en) * 1970-04-06 1972-02-08 Dover Molded Products Co Throwaway closure for test tube
US3861395A (en) 1973-09-25 1975-01-21 Tokuso Taniguchi Automated catheter
US3968876A (en) * 1975-03-19 1976-07-13 Brookfield Richard A Sealed container with a sterilized hypodermic needle within it and method for effecting the sealing thereof
US4137916A (en) * 1976-11-22 1979-02-06 Travenol Laboratories, Inc. Catheter plug assembly
US4834711A (en) * 1987-08-14 1989-05-30 Greenfield Albert R Dispensing appliance for insertion and maintenance of catheters, tubes and other articles of therapy
US4925448A (en) * 1988-03-30 1990-05-15 The Cleveland Clinic Foundation Catheter package
US5154327A (en) * 1990-04-05 1992-10-13 Long Kyle D Sealable nozzle adaptor for use with a caulking tube cartridge
US5217114A (en) * 1991-05-15 1993-06-08 Applied Vascular Devices, Inc. Catheter package
US5209726A (en) 1992-05-04 1993-05-11 Goosen Carl C Self-lubricating urethral catheter and method for self-catheterization
US5454798A (en) 1993-05-14 1995-10-03 Mentor Corporation Disposable urine bag
SE9600276D0 (en) 1996-01-25 1996-01-25 Astra Ab A wetting device for wetting a hydrophilic catheter and a urine collection bag incorporating said device
US6004305A (en) * 1996-05-03 1999-12-21 Spectrum Medsystems, Inc. Drainage catheter assembly
DK172941B1 (en) * 1996-09-18 1999-10-11 Coloplast As A urinary catheter assembly
US5792114A (en) * 1996-12-16 1998-08-11 Fiore; John M. Introducer for sterile insertion of catheter
US6053905A (en) 1998-02-23 2000-04-25 Tyco International (Us) Inc. Self contained urethral catheter assembly with lubricating chamber
US6090075A (en) 1998-03-31 2000-07-18 House; Jamie Glen Disposable urinary catheterization assembly
SE9904635D0 (en) 1999-12-17 1999-12-17 Astra Ab Catheter wetting apparatus
US6375051B1 (en) * 2000-10-16 2002-04-23 Richard A. Iverson Caulk storage and dispensing system with a reusable closure device
US6387073B1 (en) * 2000-12-06 2002-05-14 Weiler Engineering, Inc. Hermetically sealed container with medicament storing and dispensing insert
US7311698B2 (en) 2001-09-24 2007-12-25 Coloplast A/S Urinary catheter assembly allowing for non-contaminated insertion of the catheter into a urinary canal
US6602244B2 (en) 2001-07-19 2003-08-05 Hollister Incorporated Lubricating and gripping device for urinary catheter package
US6578709B1 (en) * 2001-07-19 2003-06-17 Hollister Incorporated Urinary catheter package and lubricator therefor with combined gripping and sealing means
US7198611B2 (en) 2002-02-11 2007-04-03 Baxter International Inc. Dialysis connector and cap having an integral disinfectant
EP1560766B1 (en) * 2002-11-13 2008-10-08 Hoffmann Neopac AG Tamper evident tube closure with twist-away centring
DE10329126B4 (en) 2003-06-27 2006-11-09 Willy Rüsch GmbH Catheter application system
US7188750B2 (en) * 2003-09-05 2007-03-13 Hospira, Inc. Blow fill sealed container with twist off top operated by overcap and method of forming the same
US20050109648A1 (en) 2003-10-30 2005-05-26 Hollister Incorporated No-touch packaging configurations and application methods for hydrophilic intermittent catheters
US7410481B1 (en) * 2004-04-06 2008-08-12 Mitts Cheryl A Urethral catheter device and method of using
US7596927B2 (en) * 2004-05-21 2009-10-06 Moser Jerry W Method of tamper proofing a container assembly with an easily opened tamper evident shrink band
WO2006121508A2 (en) 2005-05-06 2006-11-16 Hollister Incorporated Two-piece lubricant housing for urinary catheter packages
EP1922105A4 (en) 2005-08-17 2010-07-28 Colorado Catheter Company Inc Catheterization assembly
US7601158B2 (en) 2006-07-17 2009-10-13 Colorado Catheter Company, Inc. Devices for handling catheter assembly
FR2914193B1 (en) 2007-03-27 2009-06-05 Braun Medical Sas CONDITIONED INTRALUMINAL PROBE READY TO USE
US8342351B2 (en) 2007-08-03 2013-01-01 Terry J. Hobbs, SR. Cap for caulking cartridge or similar container
EP2224988A2 (en) 2007-11-29 2010-09-08 Coloplast A/S An assembly for wetting a medical device
US20110120892A1 (en) 2008-07-18 2011-05-26 Coloplast A/S Blocking device
JP2013501572A (en) 2009-08-13 2013-01-17 シー・アール・バード・インコーポレーテッド CATHETER HAVING HYDRAULIC FLUID STORAGE LOCATION AND / OR CATHETER PACKAGE USING THE CATHETER AND METHOD FOR PRODUCING AND / OR USING THE CATHETER
CA2788079C (en) 2010-01-29 2018-01-02 Monosol, Llc Improved water-soluble film having blend of pvoh polymers, and packets made therefrom
CA2793383A1 (en) * 2010-03-16 2011-09-22 Adapta Medical, Inc. Catheter reservoir seals
DK2450076T3 (en) * 2010-11-04 2017-12-04 Curan Medical B V Package with catheter
EP2545952B1 (en) * 2011-07-15 2014-04-02 Dentsply IH AB Medical device assembly
AR082385A1 (en) * 2011-07-25 2012-12-05 Lavaque Oscar A BOTTLE NECK CAPSULE CONFORMED BY AN ADHESIVE DISK AND A THERM-CONTRAIBLE HOSE, A PROCEDURE FOR THE ONLINE INCLUSION OF SUCH CAPSULE, AND A MACHINE TO CONFORM SUCH CAPSULE THROUGH SAID PROCEDURE
EP2750640B1 (en) * 2011-08-29 2018-07-25 Coloplast A/S An assembly for urinary drainage
RU2622029C2 (en) * 2011-12-09 2017-06-08 Колопласт А/С Hydraulic gates
US9327095B2 (en) * 2013-03-11 2016-05-03 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2319507A (en) * 1996-11-21 1998-05-27 Rusch Manufacturing Packaged catheter with lubricant-activating liquid
US20130079755A1 (en) * 2011-09-23 2013-03-28 Adapta Medical, Inc. Catheter Advancement
US20130079756A1 (en) * 2011-09-23 2013-03-28 Adapta Medical, Inc. Catheter Reservoir Seal

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016280443B2 (en) * 2015-06-15 2020-03-05 Hollister Incorporated Urinary catheters having limited reusability
WO2016204858A1 (en) * 2015-06-15 2016-12-22 Hollister Incorporated Urinary catheters having limited reusability
US10898675B2 (en) 2015-06-15 2021-01-26 Hollister Incorporated Urinary catheters having limited reusability
US11376395B2 (en) * 2017-07-12 2022-07-05 Hollister Incorporated Ready-to-use urinary catheter assembly
AU2018301401B2 (en) * 2017-07-12 2022-06-09 Hollister Incorporated Ready-to-use urinary catheter assembly
WO2019014344A1 (en) * 2017-07-12 2019-01-17 Hollister Incorporated Ready-to-use urinary catheter assembly
EP4233964A3 (en) * 2017-07-12 2023-09-20 Hollister Incorporated Ready-to-use urinary catheter assembly
WO2019222644A1 (en) * 2018-05-17 2019-11-21 Hollister Incorporated Methods of making sleeved hydrophilic catheter assemblies
AU2019271495B2 (en) * 2018-05-17 2023-03-09 Hollister Incorporated Methods of making sleeved hydrophilic catheter assemblies
WO2022223982A1 (en) * 2021-04-23 2022-10-27 Convatec Limited Intermittent catheter
EP4349394A2 (en) 2021-04-23 2024-04-10 ConvaTec Limited Intermittent catheter
EP4349394A3 (en) * 2021-04-23 2024-06-19 ConvaTec Limited Intermittent catheter
WO2024084202A3 (en) * 2022-10-19 2024-07-04 Convatec Limited A catheter assembly

Also Published As

Publication number Publication date
CA2923674C (en) 2021-06-08
US11813412B2 (en) 2023-11-14
HUE053380T2 (en) 2021-06-28
AU2014360561A1 (en) 2016-03-17
US20160213880A1 (en) 2016-07-28
US20210138188A1 (en) 2021-05-13
CA2923674A1 (en) 2015-06-11
ES2841177T3 (en) 2021-07-07
US20240033478A1 (en) 2024-02-01
EP3077031B1 (en) 2020-11-25
LT3077031T (en) 2021-01-11
AU2014360561B2 (en) 2018-10-25
DK3077031T3 (en) 2021-01-11
US10946172B2 (en) 2021-03-16
EP3077031A1 (en) 2016-10-12

Similar Documents

Publication Publication Date Title
US11813412B2 (en) Urinary catheter protective tips having a fluid reservoir
EP3651844B1 (en) Ready-to-use urinary catheter assembly
US10406322B2 (en) Catheter assemblies having a protective lubricious sleeve
CA2941263C (en) Intermittent catheters having hydration/gripper devices
EP3727549B1 (en) Catheter wetting devices
EP3478353B1 (en) Urinary catheter with sealed chamber
EP1858575B1 (en) A package for a medical device
EP4138970B1 (en) A wetting mechanism for a catheter
CA3160130A1 (en) Methods of making sleeved and packaged hydrophilic catheter assemblies

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14816051

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 14914822

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2923674

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2014360561

Country of ref document: AU

Date of ref document: 20141203

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2014816051

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014816051

Country of ref document: EP